WQ
UTHR icon

Wealth Quarterback’s United Therapeutics UTHR Stock Holding History

Wealth Quarterback’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2K Buy
3,143
+3,114
+10,738% +$613K ﹤0.01% 746
2021
Q2 		$6K Buy
+29
New +$5.52K ﹤0.01% 591
2020
Q2 		– Sell
-29
Closed -$2.75K – 740
2020
Q1 		$2.75K Hold
29
– – ﹤0.01% 708
2019
Q4 		$2.55K Buy
+29
New +$2.55K ﹤0.01% 733

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealth Quarterback's UTHR Position: Q3 2021 in Review

Wealth Quarterback increased its United Therapeutics (UTHR) stake by 10,738% in Q3 2021, buying an estimated $613K and bringing the position to 3,143 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Wealth Quarterback first reported a position in UTHR in Q4 2019 and has held it in 4 quarters since. The position peaked at $6K in Q2 2021. 425 funds tracked by Wall St. Rank hold UTHR as of Q3 2021.

  • Wealth Quarterback held 3,143 shares of United Therapeutics worth $2K as of Q3 2021.
  • Wealth Quarterback bought 3,114 United Therapeutics shares in Q3 2021, an estimated $613K.
  • United Therapeutics made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #746 holding.
  • Wealth Quarterback first reported a position in United Therapeutics in Q4 2019 and has held it in 4 quarters since.
  • Wealth Quarterback's United Therapeutics position peaked at $6K in Q2 2021.
  • 425 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.